All Stories

  1. The Evolving Clinical Role of Actinium-225 and Bismuth-213 for Targeted Alpha Therapy (TAT) - Production, Radiopharmaceutical Development and Clinical Applications

    Article • Current Radiopharmaceuticals, October 2018, Bentham Science Publishers

    Dr F. (Russ) F. Knapp

  2. Editorial (Thematic Issue: Lutetium-177 Labeled Therapeutics: 177Lu-PSMA is Set to Redefine Prostate Cancer Treatment)

    Article • Current Radiopharmaceuticals, November 2015, Bentham Science Publishers

    Dr F. (Russ) F. Knapp

  3. Evolving Important Role of Lutetium-177 for Therapeutic Nuclear Medicine

    Article • Current Radiopharmaceuticals, August 2015, Bentham Science Publishers

    Dr F. (Russ) F. Knapp

  4. An overview of radioisotope separation technologies for development of 188W/188Re radionuclide generators providing 188Re to meet future research and clinical demands

    Article • RSC Advances, January 2015, Royal Society of Chemistry

    Dr F. (Russ) F. Knapp